MGPS & l'INRA
The microbiota in human health
and well being.

Expertise

MetaGenoPolis (MGP) is a “Demonstration” project funded by the French initiative Future investments . It aims to establish the impact of the human gut microbiota on health and disease, applying quantitative and functional metagenomics technologies.

Characterization of the human microbiota enables the study of its variation with population, genotypes, disease, age, nutrition, medication and environment, and therefore opening avenues to modify it, in order to optimize the health and wellbeing of any individual.

To support this goal, MGP has developed a center of excellence in Human Intestinal Metagenomics dedicated to translational research needs of the medical, academic and industrial communities and brings together several know-how and expertise gathered into 4 scientific platforms accompanied by an ethical center:

Domaines de recherches :
Biobanking - Quantitative metagenomics - Functional metagenomics
Plateformes Scientifiques :
SAMBO - METAQUANT - INFOBIOSTAT - METAFUN - SOCA